ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) last traded at $70.84, down 3.74% on the session. The quote above updates while this page is open; the figures below are drawn from ANI Pharmaceuticals, Inc.’s own filings and are restated only when a new one is published.
ANI Pharmaceuticals, Inc. trades on NASDAQ under the ticker ANIP. Its market capitalisation is $1.59 billion.
Valuation measures for ANI Pharmaceuticals, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $1.59B |
|---|---|
| Enterprise value | $2.13B |
| P/E ratio | 15.40 |
| Price / sales | 1.63 |
| Price / book | 2.67 |
| Beta | 0.26 |
Trailing-twelve-month figures tagged in ANI Pharmaceuticals, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $978.38M |
|---|---|
| Net income (TTM) | $108.31M |
| EPS (TTM) | $4.60 |
| Operating margin | 15.37% |
| Return on equity | 18.14% |
| Cash | $360.21M |
Range and volume for ANIP over the past 52 weeks.
| 52-week high | $97.00 |
|---|---|
| 52-week low | $69.58 |
| Volume | 331.8K |
| Average volume | 378.5K |
| Previous close | $73.59 |
Invest a chosen dollar amount in ANI Pharmaceuticals, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ANIP.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.